As age and Parkinson's disease (PD) both play a role in the degeneration of brain white matter, we aimed to investigate a possible interaction effect of age and disease presence on white matter integrity in PD. We studied white matter hyperintensity volume, global fractional anisotropy, mean diffusivity and mean magnetic transfer ratio of normal appearing white matter in 163 PD patients and 218 age-and gender matched healthy control subjects. We investigated the relationship between age and these parameters in both groups, and interaction between age and disease presence. PD patients had a higher load of white matter hyperintensities with a preferential periventricular and anterior distribution as compared to healthy controls. Visuospatial functioning was related to total and postural instability and gait difficulty were related to periventricular white matter hyperintensity volume in PD. The age-related decline of white matter integrity was similar for both groups. Global microstructural integrity of the normal appearing white matter did not differ between patients and healthy control subjects, suggesting that PD-specific changes do not exceed normal age-associated change in white matter without lesions.
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3 (Jellinger, 2012; Kramer and Schulz-Schaeffer, 2007) . The primary determinant of neurodegeneration in PD may be α-synuclein aggregate related synaptic and axonal dysfunction (Jellinger, 2012; O'Malley, 2010; Tagliaferro et al., 2015) . White matter changes represent degeneration of axons and myelin damage, and white matter degeneration is increasingly recognized in PD (Chiang et al., 2017; Chondrogiorgi et al., 2016; Sterling et al., 2017) .
Magnetic resonance imaging (MRI) studies have found white matter changes in PD (AtkinsonClement et al., 2017; Bohnen and Albin, 2011 ), but such changes may occur as a consequence of aging (Galluzzi et al., 2008; Lockhart and DeCarli, 2014) . With advancing age, the prevalence of white matter hyperintensities (WMHs) increases (Galluzzi et al., 2008; Grueter and Schulz, 2012) , and white matter microstructural integrity surrounding these lesions (the so called normal appearing white matter; NAWM), declines (Lockhart and DeCarli, 2014; Vernooij et al., 2008) . These findings thus raise the question to what extent white matter changes in PD are related to aging.
We hypothesized that the white matter integrity decline is significantly greater in PD patients than seen in healthy ageing subjects and that there may be an age-by-PD interaction effect on white matter integrity. To this end, we compared macro-and microstructural integrity of global white matter and the microstructural integrity of the surrounding NAWM between PD patients and control subjects. The relationship between age and white matter integrity was estimated in both groups, and the interaction between age and disease presence was examined in order to investigate if agerelated white matter changes are different in PD compared with healthy aging. We further explored associations of clinical variables, other than age, with white matter integrity.
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5 dysfunction, cognitive impairment and depressive symptoms (total range: 0-54) (Van der Heeden JF, Marinus J, Martinez-Martin P, 2016) . Higher scores on both scales reflect more severe impairment.
Cognitive performance was assessed with the SCOPA-COG (SCales for Outcomes in PArkinson's disease-COGnition; cognitive functioning; range 0-43), which is a valid and reliable instrument examining the following domains: memory, attention, executive functioning and visuospatial functioning (Marinus et al., 2003) ; lower scores reflect more severe impairment. A levodopa dose equivalent (LDE) was calculated according to the formula developed by Tomlinson et al. (Tomlinson et al., 2010) . Patients were further asked if they had vascular risk factors: smoking, myocardial infarction, diabetes mellitus, hypertension, use of statins, transient ischemic attack and stroke, although previous stroke was an exclusion criterion for the study.
MRI acquisition and analysis
Imaging was performed on a 3 Tesla MRI scanner (Philips Achieva, Best, the Netherlands). Threedimensional T1-weighted anatomical images were acquired with the following parameters: repetition time (TR)/echo time (TE) = 9.8/4.6 ms, flip angle = 8°, field of view (FOV) = 220 x 174 x 156 mm, voxel size = 1.15 x 1.15 x 1.20 mm. Fluid attenuated inversion recovery (FLAIR) images were acquired with TR/TE = 9249/56 ms, flip angle = 90°, FOV = 220 x 220 x 128 mm, voxel size = 1.96 x 1.96 x 2.00 mm. DTI images were acquired along 32 non-collinear directions with a b-value of 1000 s/mm 2 and one b = 0 image with TR/TE = 9249/56 ms, flip angle = 90°, 32 axial slices, voxel size = 1.96
x 2.00 x 2.00 mm, FOV = 220 x 220 x 128. MTI parameters were: TR/TE = 100/11 ms, flip angle = 9°, voxel size = 1.00 x 1.00 x 7.20 mm, FOV = 224 x 180 x 144 mm. Before analysis, all MRI scans were visually checked to ensure that no major artifacts or abnormalities were present in the data. MR images were analyzed with software provided by FSL (version 5.0.8, Oxford, United Kingdom) (Smith et al., 2004) .
White matter hyperintensities
WMH volume was quantified in an automated manner, defined as hyperintense regions on FLAIR.
The T1-weighted images were brain-extracted (Smith, 2002) and FLAIR and T1-weighted images were non-linearly registered to MNI standard space (Andersson et al., 2007) . White matter was extracted from the FLAIR image using an MNI152 white matter mask. A threshold of 2.5 standard deviations above the mean of FLAIR intensities for white matter was set to identify which white matter voxels were hyperintense. We additionally calculated WMH volumes for periventricular and deep white matter (Fazekas et al., 1987) . We created a periventricular white matter mask by subtracting an MNI ventricle mask from an MNI ventricle mask that was dilated using a 4 x 4 x 4 kernel. An anterior deep white matter mask was created using the anterior part of the previously used MNI white matter mask (most frontal part of the corpus callosum, MNI coordinate Y = 33), of which the periventricular white matter mask was subtracted. A posterior deep white matter mask was created similarly (most posterior part of the corpus callosum, MNI coordinate Y = -44).
Diffusion tensor imaging
The preprocessing of the DTI data consisted of brain extraction (Smith, 2002) , motion and eddy current correction (Andersson and Sotiropoulos, 2016) . The corrected DTI was subsequently used to create individual fractional anisotropy (FA) and mean diffusivity (MD) images using a weighted least squares fitting procedure. All subjects' FA and MD data were aligned into a common space using nonlinear registration (Andersson et al., 2007) . The resulting images were used for quantification of global mean FA and MD values of each subjects NAWM (i.e. white matter without lesions). T1-weighted images were brain-extracted (Smith, 2002) and segmented in order to create individual white matter masks (Zhang et al., 2001) , which were linearly registered to MNI space (Jenkinson et al., 2002) . Then, WMHs of each subject were dilated using a 3 x 3 x 1 kernel and subtracted from the individual white matter mask in order to create a NAWM mask. Finally, individual mean FA and MD values were calculated using the normal appearing white matter mask.
Voxel-wise statistical analyses of the FA and MD data were carried out with Tract-Based Spatial Statistics (TBSS), using default settings (Smith et al., 2006) . TBSS projects all subjects' aligned FA (or MD) data onto a mean white matter tract skeleton. The resulting four-dimensional data was used for further statistical analysis.
Magnetization transfer imaging
The MT images and the previously derived individual NAWM (WMHs subtracted from white matter)
were linearly registered to T1 space (Jenkinson et al., 2002) . Global magnetic transfer ratio (MTR) values were calculated per voxel as (M0 -Ms) / M0 (Ms: saturated image; M0: unsaturated image).
MTR histograms were generated using the normal appearing white matter mask in order to calculate the mean MTR from each histogram, which is the mean of the MTR value of all voxels in the histogram.
Statistical analysis
Differences between patients and control subjects in WMH volumes, global mean FA, MD and mean MTR values of NAWM (white matter integrity measurements) and age were analyzed with independent-sample T-tests, dichotomous variables using a chi-square test or Fisher exact test. We used linear regression analyses for estimating the relationships between age and measurements of white matter integrity in patients and control subjects. Total WMH volumes were transformed using the logarithm function to meet normality assumptions. We examined the interaction between age and disease presence on white matter integrity (dependent variable) in a general linear model, with disease presence and age also included as independent variables; gender was included in the model as an independent variable as well. Within the PD group, we used a linear regression analysis to estimate the relationships between clinical variables (independent variable; disease duration, MDS-UPDRS motor, SENS-PD and SCOPA-COG score, total LDE, presence of vascular risk factors and hypertension) and WMH volumes (dependent variable; total, deep anterior and periventricular WMH M A N U S C R I P T Voxel-wise statistical analysis of the FA and MD data was carried out using a general linear model approach as implemented in FSL, with gender used as covariate in the model as we did in the other statistical analyses. The spatial relationship between age and FA, and age and MD data was studied in the PD as well as in the control group. Permutation-based non-parametric testing was used (Winkler et al., 2014) , with 5000 permutations, correcting for multiple comparisons across space. The statistical threshold was set at p < 0.05, Family-Wise Error (FWE) corrected, using the Threshold-Free Cluster Enhancement (TFCE) technique (Smith and Nichols, 2009 ).
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Results
Demographic characteristics
There were no statistically significant differences in age and gender between the patient and the control group (table 1) . PD patients had higher WMH volumes (p < 0.001) compared to control subjects. The periventricular (p < 0.001) and deep anterior (p < 0.001) WMH volumes were larger in PD patients than in control subjects. We did not find statistically significant differences in deep posterior WMH volumes, and also white matter microstructure parameters (i.e., FA, MD, MTR) did not significantly differ between groups.
Age and white matter hyperintensity volume
In the PD group as well as in the control group, total WMH volume increased with age (PD group: β = .329, p < 0.001; control group: β = .341, p < 0.001; see figure 1a ). There was no statistically significant interaction of age and disease presence in their effects on WMH volume. Periventricular (PD group: β = .364, p < 0.001; control group: β = .364, p < 0.001) and deep posterior (PD group: β = .242, p < 0.002; control group: β = .312, p < 0.001) WMH volumes also increased with age, but anterior WMH volume did not.
We found that in the PD group, visuospatial functioning (SCOPA-COG score) was related to 
Age and global white matter microstructural integrity
Age had a statistically significant association with FA (PD group: β = -.380, p < 0.001; control group: β = -.392, p < 0.001; see figure 1b), MD (PD group: β = .522, p < 0.001; control group: β = .528, p < 0.001; see figure 1c ) and mean MTR (PD group: β = -.470, p < 0.001; control group: β = -.393, p < 0.001; see figure 1d ) in both groups. There was no statistically significant interaction effect of age and disease presence on FA, MD or mean MTR.
We used TBSS to investigate the spatial voxel-wise relationship between age and FA and MD values in the PD as well as in the control group (figure 2). This shows that the spatial effect of age on FA and MD is distributed throughout the entire brain across white matter tracts in both PD patients and control subjects.
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Discussion
As age and PD both play a role in the degeneration of brain white matter, we investigated the relationship between age and white matter integrity in PD patients and control subjects.
Although PD patients had a higher load of white matter lesions, the influence of age on the decline of white matter integrity was similar to controls. In both groups, measures of white matter integrity were associated with advancing age, which appeared homogeneously distributed across white matter tracts. No differences were found in the degree of NAWM degeneration.
The PD patients in this study had a higher WMH load than expected for their age. The excess of WMHs was partly located in periventricular and deep frontal white matter of PD patients. Besides age, visuospatial functioning and postural instability and gait difficulty were related to WMH volume in PD patients. Given the similar age-related increase of WMHs in PD patients and control subjects, our findings may suggest that the pathobiology of PD plays a role in the development of WMHs. Our findings are in line with those of other studies showing more WMHs in PD (Compta et al., 2016; Dunet et al., 2018; Ham et al., 2016; Piccini et al., 1995) . Nevertheless, other studies did no show differences between PD patients and healthy control subjects (Acharya et al., 2006; Beyer et al., 2006; Dalaker et al., 2009; Sartor et al., 2017) . Differences in field strength (ranging from 0.5 to 3 Tesla), methodology to asses WMHs and selection of a specific subset of PD patients (i.e.
with/without dementia or mild cognitive impairment) in these studies likely contributed to the inconsistent findings. Importantly, previous MRI studies investigating WMHs in PD used visual rating scales, such as the Fazekas grading system and the Scheltens visual rating scale, or semi-automated visual approaches that require manual contouring of the lesions. Increased field strength can possibly result in a better delineation of white matter lesions (Zwanenburg et al., 2010) and the accuracy of visual rating systems may depend on the WMH load. Some scales do not discriminate between no abnormalities and few WMHs or moderate and severe quantities of WMHs, or suffer from ceiling effects in patients with a more extensive WMH load (Tiehuis et al., 2008; Wardlaw et al., 2004) . The
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11 automated threshold method to measure WMH volume used in our study, however, provides objective and quantitative data (Tiehuis et al., 2008) .
Previous studies have shown that WMHs independently contribute to postural instability and gait difficulty in PD as well (for review, see (Bohnen and Albin, 2011) ). There are indications that WMHs may have a substantial impact especially on axial motor disability (Lee et al., 2009; Moccia et al., 2016) . There are also indications that WMHs contribute to cognitive impairment in PD (Dadar et al., 2018; Veselý and Rektor, 2016) . A recent study found increased MD in frontal and parietal white matter tracts in newly diagnosed, cognitively intact, PD patients as compared to control subjects, which was related to cognitive performance tasks (Duncan et al., 2016) . These findings suggest that white matter may already be affected in the very early stages of PD, predicting future cognitive decline (Dadar et al., 2018; Duncan et al., 2016; Veselý and Rektor, 2016) . However, some studies reported that the correlations found between cognitive measures and WMHs disappeared after adjusting for strong confounders, such as age (Bohnen and Albin, 2011; Lee and Lee, 2016) . Indeed, our findings show that postural instability, gait difficulty and visuospatial functioning are related to the total and to periventricular WMH volume in PD patients, but the relationship between visuospatial functioning and WMHs weakened after adjustment for the effect of age in our study too. Also, the relationship between age and WMHs appeared stronger than the relationship between visuospatial functioning and WMHs. WMHs might exacerbate cognitive or motor dysfunction in PD trough aggravation of already impaired neuronal connectivity (Veselý and Rektor, 2016) . Especially periventricular WMHs could interfere with cortico-subcortical circuits that are important for gait and balance (Blahak et al., 2009; Bohnen and Albin, 2011) . It is debatable whether the associations that we found are specific for PD, as WMHs are associated with motor and cognitive symptoms in otherwise normal elderly individuals as well (Bohnen and Albin, 2011) .
WMHs have been linked to vascular disease, including depositions of amyloid-β (Pantoni, 2010) . A recent study found more severe WMH burden in PD patients with dementia compared to non-demented PD patients and control subjects, which was related to decreased amyloid-β levels in M A N U S C R I P T
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12 the cerebrospinal fluid in the entire PD sample. Since this finding was independent of age, dementia, APOE-4 and vascular risk factors, the authors suggested a possible relationship between brain amyloid deposition and the occurrence of WMHs in PD (Compta et al., 2016) . At this stage it remains unclear whether the relationship between amyloid-β levels in the cerebrospinal fluid and WMHs in PD also reflects vascular amyloid-β deposition. Periventricular WMHs may further result from chronic hemodynamic insufficiency (hypoperfusion), Wallerian degeneration secondary to neocortical neuron loss in neurodegenerative diseases (Bohnen and Albin, 2011; Kim et al., 2008; Leys et al., 1991) , or low grade inflammation (Bohnen and Albin, 2011; Wersching et al., 2010) to which regional differences in gene expression may contribute, resulting in a spatial distribution of pathogenic pathways (Ritz et al., 2017) .
The micro-integrity of the white matter in PD patients without WMHs was normal in terms of global FA, MD and MTR, compared to age-matched control subjects. Previous cross-sectional studies have shown that DTI and MTR are particularly relevant for subcortical areas (Atkinson-Clement et al., 2017; Tambasco et al., 2015) , and show conflicting results in cortical white matter, which might be explained by the low statistical power due to small sample sizes these studies (Atkinson-Clement et al., 2017; Hall et al., 2016; Tambasco et al., 2015) . A recent meta-analysis, however, suggested that the cognitive status of PD patients is associated with damage in the temporal and cingulate cortices (Atkinson-Clement et al., 2017) . A major difference between previously conducted studies and our study is that these studies generally applied region of interest approaches (Cochrane and Ebmeier, 2013; Tessitore et al., 2016) , while we used global FA and MD measures of white matter, in order to investigate the relationship between age and global white matter integrity in PD. Two previous longitudinal studies used a whole brain white matter approach as well, and observed similar levels of decline in white matter integrity in PD patients and control subjects (Melzer et al., 2015; Rossi et al., 2014 
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13 white matter (Pozorski et al., 2018; Zhang et al., 2016) . Collectively, all findings suggest that PDspecific changes do not exceed normal age-associated change in cortical white matter tracts.
The strengths of our study are the large sample PD patients and control subjects in whom we performed structural MRI as well as DTI and MTR in order to investigate the relationship between age and white matter integrity. We further used automated techniques for individual quantification of WMH volume, based on thresholding of hyperintense white matter voxels, which have the advantage of improved quantitative assessment of WMHs compared with visual grading (Bohnen and Albin, 2011) . A limitation of our study is the cross-sectional design to assess the age-related decline of white matter, as cross-sectional data relies on between-person comparisons, and not models intra-individual change. White matter changes, ageing and cardiovascular risk factors are closely related to each other (Debette and Markus, 2010; Erten-Lyons et al., 2013; Wardlaw et al., 2013) . It could be assumed that the control subjects in this study, which were selected from the Leiden Longevity Study, may have had a more favorable cardiovascular risk profile as compared to the PD patients in this study. However, cardiovascular risk factors did not differ between groups, although it should be noted that the assessed cardiovascular risk factors may not have been complete (e.g. the use of statins were compared, but not the presence of hyperlipidemia). Of note is that there were more missing values in the control group than in the patient group, but we consider it unlikely that this may have led to additional bias since there is no reason to assume a relationship between missingness and the risk profile of the patient. WMH volume may be associated with a worse response to dopaminergic medication for postural stability and gait difficulty (Arena et al., 2016) . We therefore added total-LDE score to the model but this did not change our results. The effects of dopaminergic medication on white matter microstructure are not really known, except for one study that showed that DTI is not affected by acute antiparkinsonian medication (Chung et al., 2017) . In our study, micro-integrity of white matter without WMHs did not differ between PD patients and agematched control subjects, but subtle differences between groups may become apparent through the use of a region of interest approach (Pozorski et al., 2018; Zhang et al., 2016) . Also, the rate of age-M A N U S C R I P T
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14 related change may vary across multiple white matter regions, although the spatial effect of age on FA and MD was uniformly distributed across white matter tracts in both groups.
Conclusion
PD patients had a higher load of WMHs with a preferential periventricular and anterior distribution as compared to healthy controls. Visuospatial functioning was related to total and postural instability and gait difficulty were related to periventricular WMH volume in PD. The age-related decline of white matter integrity was similar for both groups. Global FA, MD and MTR of the NAWM was relatively normal in PD patients, suggesting that PD-specific changes do not exceed normal ageassociated change in white matter without lesions. Disease duration, years 9.1 (4.9) n/a n/a MDS-UPDRS motor score (0-132) 34.3 (15.6) n/a n/a SENS-PD (0-54) 13.2 (6.1) n/a n/a SCOPA-COG (0-43) 27.5 (11 -41) n/a n/a Total LDE, mg/day 1017.1 (558.7) n/a n/a 
Highlights
• PD patients had more WMHs as compared to control subjects
• WMHs had a preferential periventricular and anterior distribution in PD
• The age-related decline of white matter integrity was similar for both groups
• Global microstructural integrity was relatively normal in PD
